Analyze Diet
Research in veterinary science1976; 20(1); 84-89;

Pharmacological experiments as a basis for the administration of digoxin in the horse.

Abstract: It is shown that the concentration of ouabain necessary for 50 per cent inhibition of the Na+K activated membrane ATPase of red cells is similar in man and horse. This is taken to indicate that the two species have similar sensitivity towards cardiac glycosides in general. In five adult healthy horses plasma digoxin concentration was measured with a radioimmunoassay technique after a single intravenous injection of 1 mg/100 kg body weight digoxin. The half time of elimination was 23 h and the apparent volume of distribution 7.3 litres/kg. An approximate estimate of plasma protein binding of digoxin was obtained by measuring digoxin with a fluorimetric assay in the ultrafiltrate from horse plasma containing 2-20 mug/ml. At concentrations below 10(-5)(g/ml 20 to 40 per cent of digoxin present in horse plasma is bound to protein. With this information and by using effective digoxin concentration measured in humans an average daily maintenance dose of 0-5-0-75 mg/100 kg body weight was calculated which may serve as a guideline in the treatment of congestive heart failure with digoxin in the horse.
Publication Date: 1976-01-01 PubMed ID: 130670
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article examines the potential for using digoxin, a medication typically used to treat heart conditions in humans, in the treatment of horses. The experimental results show that horses may have a similar sensitivity to the drug as humans, with the possibility of using it effectively to treat congestive heart failure in horses.

Research Context and Methodology

  • The basis of the research was to establish an understanding of how the drug digoxin could be used in horses for heart treatment. The starting point of the investigation was the observation that the concentration of ouabain – a compound that affects sodium and potassium ion pumps in red cells – necessary for 50% inhibition of these pumps is similar in both humans and horses. This led to the hypothesis that both species might have similar sensitivity to cardiac glycosides- a class of drugs that includes digoxin.
  • To test this hypothesis, the researchers conducted a series of pharmacological experiments. Five adult healthy horses were given a single injective dose of digoxin, after which their plasma digoxin concentration was measured using a radioimmunoassay technique. This process allowed the scientists to determine how the drug was processed in the horse’s body, including measuring the half time of elimination and the apparent volume of distribution.

Results

  • From the evaluation, the scientists were able to determine that the half time of elimination for the drug was 23 hours and the apparent volume of distribution was 7.3 liters per kilogram. This means that the drug stayed in the horses’ systems for about a day and was distributed throughout a considerable volume of the horses’ bodies.
  • Additionally, the team measured the amount of digoxin bound to proteins in the horse’s plasma. They found that at certain concentrations, approximately 20 to 40 percent of digoxin in the horse’s plasma is bound to proteins.

Implications for Treatment

  • By combining the above results with previous knowledge of effective digoxin concentration in humans, the researchers calculated an average daily maintenance dose of the drug for horses. The suggested dose was between 0.5 and 0.75 mg per 100 kg of body weight. This guideline could potentially be used in the treatment of congestive heart failure with digoxin in the horse, thereby expanding the possibilities for equine cardiac treatment.

Cite This Article

APA
Francfort P, Schatzmann HJ. (1976). Pharmacological experiments as a basis for the administration of digoxin in the horse. Res Vet Sci, 20(1), 84-89.

Publication

ISSN: 0034-5288
NlmUniqueID: 0401300
Country: England
Language: English
Volume: 20
Issue: 1
Pages: 84-89

Researcher Affiliations

Francfort, P
    Schatzmann, H J

      MeSH Terms

      • Adenosine Triphosphatases / antagonists & inhibitors
      • Animals
      • Blood Proteins / analysis
      • Erythrocytes / enzymology
      • Horses / blood
      • Humans
      • Injections, Intravenous
      • Ouabain / pharmacology
      • Protein Binding

      Citations

      This article has been cited 1 times.
      1. Rasmussen F. Renal clearance: species differences and similarities.. Vet Res Commun 1983 Dec;7(1-4):301-6.
        doi: 10.1007/BF02228637pubmed: 6665989google scholar: lookup